Goldline Pharmaceutical Ltd Share Price History
BSE : 20 May, 2026
53.94-2.8 (-5.0%)
Prev Close
56.8
Open Price
53.9
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
21000
Today's High / Low
53.9 / 53.9
52 WK High / Low
60.0 / 53.9
Market Price of Goldline Pharmaceutical Ltd
1M
1Y
3Y
5Y
Monitoring Goldline Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2023 |
|---|---|
| Sales (Cr.) | 20 |
| Sales YoY Gr. | - |
| Adj EPS | 1.28 |
| YoY Gr. | - |
| Net Profit (Cr.) | 0 |
| BVPS | 20.42 |
Key Financial Parameters
| Parameter | 2023 |
|---|---|
| Return on Capital Emp. % | 12.82 |
| Op. Profit Mgn % | 12.14 |
| Net Profit Mgn % | 1.96 |
| Debt to Equity % | 1.84 |
Latest Shareholding
Promoters Holdings Over Time
About Goldline Pharmaceutical Ltd
- Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai.
- Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f.
- September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.
- Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente.
- The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Goldline Pharmaceutical Ltd's share price history?
Key events that impact Goldline Pharmaceutical Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Goldline Pharmaceutical Ltd's share price history?
Stock splits reduce the nominal price of Goldline Pharmaceutical Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Goldline Pharmaceutical Ltd?
Dividends can influence Goldline Pharmaceutical Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Goldline Pharmaceutical Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Goldline Pharmaceutical Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Goldline Pharmaceutical Ltd’s share price history?
To understand Goldline Pharmaceutical Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
